FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289754829> ?p ?o ?g. }

• W4289754829 endingPage "5722" @default.
• W4289754829 startingPage "5713" @default.
• W4289754829 abstract "Abstract The coronavirus 2019 omicron variant has surged rapidly and raises concerns about immune evasion even in individuals with complete vaccination, because it harbors mutations. Here we examine the capability of booster vaccination following CoronaVac/AZD1222 prime to induce neutralizing antibodies (NAbs) against omicron (BA.1 and BA.2) and T‐cell responses. A total of 167 participants primed with heterologous CoronaVac/AZD1222 for 4–5 months were enrolled, to receive AZD1222, BNT162b2, or mRNA‐1273 as a third dose. Reactogenicity was recorded. Immunogenicity analyses of severe acute respiratory syndrome coronavirus 2‐binding antibodies were measured using enzyme‐linked immunosorbent assay. The NAb titers against omicron BA.1 and BA.2 were determined using the focus reduction neutralization test (FRNT50) and total interferon‐γ responses were measured to observe the T‐cell activation. A substantial loss in neutralizing potency to omicron variant was found at 4–5 months after receiving the heterologous CoronaVac/AZD1222. Following booster vaccination, a significant increase in binding antibodies and neutralizing activities toward delta and omicron variants was observed. Neutralization to omicron BA.1 and BA.2 were comparable, showing the highest titers after boosted mRNA‐1273 followed by BNT162b2 and AZD1222. In addition, individuals boosted with messenger RNA (mRNA) vaccines develop a T‐cell response to spike protein, whereas those boosted with AZD1222 did not. Reactogenicity was mild to moderate without serious adverse events. Our findings demonstrated that mRNA booster vaccination is able to overcome waning immunity to provide antibodies that neutralize omicron BA.1 and BA.2, as well as a T‐cell response." @default.
• W4289754829 created "2022-08-04" @default.
• W4289754829 creator A5000380009 @default.
• W4289754829 creator A5001340042 @default.
• W4289754829 creator A5004143697 @default.
• W4289754829 creator A5006530955 @default.
• W4289754829 creator A5012247460 @default.
• W4289754829 creator A5024970229 @default.
• W4289754829 creator A5026081538 @default.
• W4289754829 creator A5026707377 @default.
• W4289754829 creator A5051156541 @default.
• W4289754829 creator A5059959150 @default.
• W4289754829 creator A5066359846 @default.
• W4289754829 creator A5067372935 @default.
• W4289754829 creator A5067511913 @default.
• W4289754829 creator A5067543646 @default.
• W4289754829 creator A5072307927 @default.
• W4289754829 creator A5078469285 @default.
• W4289754829 creator A5079500426 @default.
• W4289754829 creator A5084305363 @default.
• W4289754829 date "2022-08-10" @default.
• W4289754829 modified "2023-10-11" @default.
• W4289754829 title "Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination" @default.
• W4289754829 cites W3042833857 @default.
• W4289754829 cites W3084879098 @default.
• W4289754829 cites W3108193091 @default.
• W4289754829 cites W3129558828 @default.
• W4289754829 cites W3163785571 @default.
• W4289754829 cites W3165479483 @default.
• W4289754829 cites W3201177512 @default.
• W4289754829 cites W4206841531 @default.
• W4289754829 cites W4207048578 @default.
• W4289754829 cites W4210278951 @default.
• W4289754829 cites W4210493562 @default.
• W4289754829 cites W4210708247 @default.
• W4289754829 cites W4210737773 @default.
• W4289754829 cites W4211016470 @default.
• W4289754829 cites W4214494768 @default.
• W4289754829 cites W4220708346 @default.
• W4289754829 cites W4220807057 @default.
• W4289754829 cites W4220886953 @default.
• W4289754829 cites W4220904663 @default.
• W4289754829 cites W4220987557 @default.
• W4289754829 cites W4221072241 @default.
• W4289754829 cites W4223467041 @default.
• W4289754829 cites W4225553089 @default.
• W4289754829 cites W4225691034 @default.
• W4289754829 cites W4225760754 @default.
• W4289754829 cites W4225854071 @default.
• W4289754829 cites W4226164088 @default.
• W4289754829 cites W4226229183 @default.
• W4289754829 cites W4226343533 @default.
• W4289754829 cites W4226491433 @default.
• W4289754829 cites W4281383449 @default.
• W4289754829 doi "https://doi.org/10.1002/jmv.28044" @default.
• W4289754829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35924475" @default.
• W4289754829 hasPublicationYear "2022" @default.
• W4289754829 type Work @default.
• W4289754829 citedByCount "19" @default.
• W4289754829 countsByYear W42897548292022 @default.
• W4289754829 countsByYear W42897548292023 @default.
• W4289754829 crossrefType "journal-article" @default.
• W4289754829 hasAuthorship W4289754829A5000380009 @default.
• W4289754829 hasAuthorship W4289754829A5001340042 @default.
• W4289754829 hasAuthorship W4289754829A5004143697 @default.
• W4289754829 hasAuthorship W4289754829A5006530955 @default.
• W4289754829 hasAuthorship W4289754829A5012247460 @default.
• W4289754829 hasAuthorship W4289754829A5024970229 @default.
• W4289754829 hasAuthorship W4289754829A5026081538 @default.
• W4289754829 hasAuthorship W4289754829A5026707377 @default.
• W4289754829 hasAuthorship W4289754829A5051156541 @default.
• W4289754829 hasAuthorship W4289754829A5059959150 @default.
• W4289754829 hasAuthorship W4289754829A5066359846 @default.
• W4289754829 hasAuthorship W4289754829A5067372935 @default.
• W4289754829 hasAuthorship W4289754829A5067511913 @default.
• W4289754829 hasAuthorship W4289754829A5067543646 @default.
• W4289754829 hasAuthorship W4289754829A5072307927 @default.
• W4289754829 hasAuthorship W4289754829A5078469285 @default.
• W4289754829 hasAuthorship W4289754829A5079500426 @default.
• W4289754829 hasAuthorship W4289754829A5084305363 @default.
• W4289754829 hasBestOaLocation W42897548292 @default.
• W4289754829 hasConcept C104317684 @default.
• W4289754829 hasConcept C105580179 @default.
• W4289754829 hasConcept C14086860 @default.
• W4289754829 hasConcept C159047783 @default.
• W4289754829 hasConcept C159654299 @default.
• W4289754829 hasConcept C203014093 @default.
• W4289754829 hasConcept C22070199 @default.
• W4289754829 hasConcept C2522874641 @default.
• W4289754829 hasConcept C2777704310 @default.
• W4289754829 hasConcept C2779261636 @default.
• W4289754829 hasConcept C2780115692 @default.
• W4289754829 hasConcept C2780868878 @default.
• W4289754829 hasConcept C32611913 @default.
• W4289754829 hasConcept C54355233 @default.
• W4289754829 hasConcept C86803240 @default.
• W4289754829 hasConceptScore W4289754829C104317684 @default.
• W4289754829 hasConceptScore W4289754829C105580179 @default.

• next